TABLE 2.
Current methods for spatial transcriptomics
| Method (reference) | RNA capture method | Labeling radius | Isolation time | Sample type | Application(s) |
|---|---|---|---|---|---|
| APEX2-seq (68) | In vitro RNA isolation and library prep | 20 nm | 1 h | Cell culture, in vivo labeling | Organelles, cells, in vivo transcriptomics |
| Considerations | |||||
| Pros: excellent spatial resolution, labeling time, and read depth | |||||
| Cons: requires genetic modification of “bait” protein; subcellular pools of bait protein cannot be resolved | |||||
| TSA-seq (78) | In vitro RNA isolation and library prep | 0.5 μm | 24 h | Live/fixed cells and tissue | Organelles, cells, in situ transcriptomics |
| Considerations | |||||
| Pros: good spatial resolution and excellent read depth; applicable to primary cells/tissues | |||||
| Cons: subcellular pools of bait cannot be resolved; steric hindrance from antibody-enzyme | |||||
| LCM (81, 83, 84, 89) | Image-targeted laser ablation/polymerization | 10 μm | 3 h | Live/fixed tissue | In situ cell proteomics |
| Considerations | |||||
| Pros: user validates target region by imaging | |||||
| Cons: low RNA yield/coverage; cannot resolve single cells borders; labor- and time-intensive | |||||
| FISSEQ (99) | In situ rolling circle amplification and SOLiD | 0.4 μm | 48 h | Fresh/frozen/fixed | In situ cell transcriptomics |
| Considerations | |||||
| Pros: user validates target region by imaging; good labeling radius with in situ cDNA synthesis | |||||
| Cons: very low mRNA coverage; reliably reports only most abundant transcripts | |||||
| 10×/Visium (100) | On-slide primer array and cDNA amplification | 55 μm | ≥2 h | Fresh/frozen tissue | In situ cell transcriptomics |
| Considerations | |||||
| Pros: user validates target region by imaging; commercial platform | |||||
| Cons: low coverage confounded by weak spatial resolution (5–20 cells) of on-slide barcode array; expensive | |||||
| Slide-seq (101) | On-slide bead array and SOLiD | 20 μm | ≥3 h | Fresh/frozen tissue | In situ cell transcriptomics |
| Considerations | |||||
| Pros: reasonable spatial resolution (1–2 cells); 62% of beads in array map to 1 cell; cost-effective | |||||
| Cons: no imaging; cell type position inferred from transcripts recovered; low mRNA coverage at 100–1,000 transcripts/bead | |||||
| HDST (102) | On-slide bead array and cDNA amplification | 13 μm | ≥3 h | Fresh/frozen tissue | In situ cell transcriptomics |
| Considerations | |||||
| Pros: good spatial resolution due to binning reads in hexagonal bead array (Lightseq > HDS > Slide-seq >> 10×/Visium); 86% of transcriptome identified across entire sample | |||||
| Cons: no imaging; cell type position inferred from transcripts recovered; low mRNA coverage at 1.3% of transcripts/bead | |||||
| Light-seq (103) | Light-directed barcoding and spatial indexing | 2 μm | ≥3 h | Fixed tissue | In situ cell transcriptomics |
| Considerations | |||||
| Pros: good spatial resolution due to light-conjugated barcoding (Light-seq > HDS > Slide-seq >> 10×/Visium); pooling 25 similar cells yields 85% coverage of transcriptome ~3,500 transcripts | |||||
| Cons: specialized microscopy and photolithography reagents needed |